Sevelamer Hydrochloride Patent Expiration
Sevelamer Hydrochloride is Used for managing hyperphosphatemia in chronic kidney disease. It was first introduced by Genzyme Corp
Sevelamer Hydrochloride Patents
Given below is the list of patents protecting Sevelamer Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Renagel | US5496545 | Phosphate-binding polymers for oral administration |
Aug 11, 2013
(Expired) | Genzyme |
| Renagel | US5667775 | Phosphate-binding polymers for oral administration |
Sep 16, 2014
(Expired) | Genzyme |
| Renagel | US6509013 | Method of making phosphate-binding polymers for oral administration |
Aug 11, 2013
(Expired) | Genzyme |
| Renagel | US6733780 | Direct compression polymer tablet core |
Oct 18, 2020
(Expired) | Genzyme |
| Renagel | US7014846 | Phosphate-binding polymers for oral administration |
Aug 11, 2013
(Expired) | Genzyme |
| Renagel | US7459151 | Phosphate-binding polymers for oral administration |
Aug 11, 2013
(Expired) | Genzyme |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Sevelamer Hydrochloride's patents.
Latest Legal Activities on Sevelamer Hydrochloride's Patents
Given below is the list recent legal activities going on the following patents of Sevelamer Hydrochloride.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 21 May, 2020 | US7459151 |
| Expire Patent Critical | 18 Apr, 2014 | US7014846 |
| Patent Issue Date Used in PTA Calculation Critical | 02 Dec, 2008 | US7459151 |
| Recordation of Patent Grant Mailed Critical | 02 Dec, 2008 | US7459151 |
| Issue Notification Mailed Critical | 12 Nov, 2008 | US7459151 |
| Application Is Considered Ready for Issue Critical | 29 Oct, 2008 | US7459151 |
| Dispatch to FDC | 29 Oct, 2008 | US7459151 |
| Issue Fee Payment Received Critical | 28 Oct, 2008 | US7459151 |
| Issue Fee Payment Verified Critical | 28 Oct, 2008 | US7459151 |
| Pubs Case Remand to TC Critical | 09 Sep, 2008 | US7459151 |
Try Our Curated Drug Screens
Sevelamer Hydrochloride Generics
Several generic applications have been filed for Sevelamer Hydrochloride. The first generic version for Sevelamer Hydrochloride was by Glenmark Pharmaceuticals Ltd and was approved on Feb 8, 2019. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Jul 11, 2023.
Given below is the list of companies who have filed for Sevelamer Hydrochloride generic.
1. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Sevelamer Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 400MG | tablet | Prescription | ORAL | AB | Jul 11, 2023 |
| 800MG | tablet | Prescription | ORAL | AB | Jul 11, 2023 |
2. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Sevelamer Hydrochloride. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Prescription | ORAL | AB | Feb 8, 2019 |
| 400MG | tablet | Prescription | ORAL | AB | Feb 8, 2019 |
3. LUPIN LTD
Lupin Ltd has filed for 2 different strengths of generic version for Sevelamer Hydrochloride. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Prescription | ORAL | AB | Jun 16, 2021 |
| 400MG | tablet | Prescription | ORAL | AB | Jun 16, 2021 |
4. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Sevelamer Hydrochloride. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 400MG | tablet | Prescription | ORAL | AB | May 26, 2023 |
| 800MG | tablet | Prescription | ORAL | AB | May 26, 2023 |
5. RISING
Rising Pharma Holding Inc has filed for 2 different strengths of generic version for Sevelamer Hydrochloride. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800MG | tablet | Discontinued | ORAL | N/A | Dec 14, 2020 |
| 400MG | tablet | Discontinued | ORAL | N/A | Dec 14, 2020 |